Antibiotic Application Ointment
NDC Package 49687-0013-0
Package Information
Antibiotic Application (bacitracin zinc, neomycin sulfate, polymyxin b sulfate) ointment is • Flush the affected eye as needed, controlling the rate of flow of solution by pressure on the bottle • Clean the affected area. This formulation utilizes a ointment delivery system. Marketed by Cmc Group, Inc., this product is identified by NDC 49687-0013 and is authorized under FDA application M003.
Identification & Billing
- RxCUI: 1012100 - benzalkonium chloride 0.13 % / lidocaine HCl 0.5 % Topical Cream
- RxCUI: 1012100 - benzalkonium chloride 1.3 MG/ML / lidocaine hydrochloride 5 MG/ML Topical Cream
- RxCUI: 1012100 - benzalkonium chloride 0.13 % / lidocaine hydrochloride 0.5 % Topical Cream
- RxCUI: 1038558 - benzalkonium chloride 0.13 % Medicated Pad
- RxCUI: 1038558 - benzalkonium chloride 1.3 MG/ML Medicated Pad
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 49687 - Cmc Group, Inc.
- 49687-0013 - Antibiotic Application
- 49687-0013-0 - 10 PACKAGE in 1 KIT / .9 g in 1 PACKAGE
- 49687-0013 - Antibiotic Application
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 49687-0013-0 identifies a specific commercial package of 10 package in 1 kit / .9 g in 1 package of Antibiotic Application, a human over the counter drug labeled by Cmc Group, Inc.. This ointment is formulated for topical use and contains bacitracin zinc; neomycin sulfate; polymyxin b sulfate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cmc Group, Inc. on August 06, 2016. The current certification is valid through December 31, 2026.
How is this Cmc Group, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 49687001300. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.